https://www.theverge.com/2022/8/24/23310522/apple-iphone-14-event-announcement-date-time-september-2022
Opdivo In Combination With Cisplatin-Based Chemotherapy Followed By Opdivo Demonstrates Significant Survival Benefits For Cisplatin-Eligible Patients with Unresectable Or Metastatic Urothelial Carcinoma In Phase 3 CheckMate -901 Trial
Opdivo in combination with cisplatin-based chemotherapy followed by Opdivo monotherapy reduced the risk of death by 22% for patients with unresectable or metastatic urothelial carcinomaCheckMate -901 is the first Phase 3
